Journal of gastroenterology and hepatology · 2026
Bacteroides thetaiotaomicron Improves Colorectal Cancer Prognosis by Remodeling the Immune Microenvironment.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shi Zesheng, Zou Deling, Hong Shaoming, Yu Yashi, Guo Zipei
Аннотация
BACKGROUND: Colorectal cancer (CRC) progression is closely associated with gut microbiota. Bacteroides thetaiotaomicron (B.theta), a key species in the human cecal and colonic microbiota, plays an incompletely defined role in CRC progression.
METHODS: CRC animal models were established utilizing immunocompetent C57BL/6 mice and immunodeficient BALB/C nude mice. Histopathological changes were assessed by H&E staining. Immune cell infiltration was evaluated by IHC. CD8+ T cells and cancer cells were treated with B.theta culture supernatant. Cytokine secretion was measured by ELISA. Surface protein expression levels on CD8+ T cells and cancer cell apoptosis were analyzed by flow cytometry. CD8+ T cell proliferation was determined by the CFSE assay. Tumor-killing activity of CD8+ T cells was assessed by LDH release assay.
RESULTS: In C57BL/6 mice, B.theta suppressed tumor development and promoted T cell infiltration. However, B.theta had no significant impact on CRC progression in BALB/C nude mice. B.theta supernatant treatment did not affect CRC cell phenotypes, including viability, apoptosis, MHC-I expression, and extracellular ATP levels. Conversely, B.theta supernatant upregulated CD69 and CD44 expression on CD8+ T cells, promoted IFN-γ and TNF-α secretion, enhanced proliferation, and consequently augmented their cytotoxicity against CRC cells.
CONCLUSION: B.theta suppresses malignant CRC progression by modulating host immune responses.
METHODS: CRC animal models were established utilizing immunocompetent C57BL/6 mice and immunodeficient BALB/C nude mice. Histopathological changes were assessed by H&E staining. Immune cell infiltration was evaluated by IHC. CD8+ T cells and cancer cells were treated with B.theta culture supernatant. Cytokine secretion was measured by ELISA. Surface protein expression levels on CD8+ T cells and cancer cell apoptosis were analyzed by flow cytometry. CD8+ T cell proliferation was determined by the CFSE assay. Tumor-killing activity of CD8+ T cells was assessed by LDH release assay.
RESULTS: In C57BL/6 mice, B.theta suppressed tumor development and promoted T cell infiltration. However, B.theta had no significant impact on CRC progression in BALB/C nude mice. B.theta supernatant treatment did not affect CRC cell phenotypes, including viability, apoptosis, MHC-I expression, and extracellular ATP levels. Conversely, B.theta supernatant upregulated CD69 and CD44 expression on CD8+ T cells, promoted IFN-γ and TNF-α secretion, enhanced proliferation, and consequently augmented their cytotoxicity against CRC cells.
CONCLUSION: B.theta suppresses malignant CRC progression by modulating host immune responses.
Предметные рубрики MeSH
AnimalsColorectal NeoplasmsCD8-Positive T-LymphocytesMice, Inbred C57BLMice, Inbred BALB CTumor MicroenvironmentBacteroides thetaiotaomicronDisease Models, AnimalApoptosisMice, NudePrognosisInterferon-gammaAntigens, CDHumansCytokinesCell ProliferationTumor Necrosis Factor-alphaLectins, C-TypeDisease ProgressionAntigens, Differentiation, T-LymphocyteHyaluronan ReceptorsCD69 Antigens